Cite
HARVARD Citation
Kan, H. et al. (2016). Combination Therapies with Daclatasvir and Asunaprevir on NS3-D168 Mutated HCV in Human Hepatocyte Chimeric Mice. Antiviral therapy. 21 (4), pp. 307-315. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kan, H. et al. (2016). Combination Therapies with Daclatasvir and Asunaprevir on NS3-D168 Mutated HCV in Human Hepatocyte Chimeric Mice. Antiviral therapy. 21 (4), pp. 307-315. [Online].